个性化加速生理双速节奏对心脏氨基粉症进行节奏
Markus Meyer1, Valmiki Maharaj1, Sneha Nandy1
1Department of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota, USA.
JACC. Case reports
|December 18, 2024
概括
一个双心室起器有效地治疗了心脏粉样化症患者的鼻肌梗塞和低血压. 持续加快速度节奏显著改善了患者的健康状况和症状.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 心脏 Amyloidosis 可以导致严重的胸肌梗塞和低血压.
- 心脏起器植入是一种潜在的治疗症状勃拉迪亚心律失常症.
研究的目的:
- 为了评估先进的双心室心脏起器系统的有效性,持续加快节奏节奏在心脏粉症患者呈现与鼻肌梗塞和症状性低血压.
主要方法:
- 患者接受了双心室起器系统.
- 实现了连续加速节拍,白天设置70次/分钟,晚上设置90次/分钟.
主要成果:
- 患者在植入后三个月的健康状况和症状明显改善.
- 双心室起器有效地控制了鼻肌梗塞和症状性低血压.
结论:
- 带有连续加速率节奏的高级双心脏节奏是一种可行的和有效的治疗方法,用于控制心肌和心肌粉症患者的症状性低血压.
更多相关视频
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


